Ácido piroglutámico (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ácido piroglutámico" in Galician language version.

refsWebsite

Global rank Galician rank

8nih.gov

4^th place

6^th place

7doi.org

2^nd place

7^th place

1currentscience.ac.in

9,156^th place

8,451^st place

1jstor.org

26^th place

72^nd place

1evidence.nhs.uk

low place

1books.google.com

3^rd place

12^th place

books.google.com

Jungermann, Eric; Sonntag, Norman O.V (1991-07-19). "Alternatives to Glycerine". En Eric Jungermann; Norman O.V. Sonnta. Glycerine: A Key Cosmetic Ingredient. p. 424. ISBN 978-0-8247-8465-2.

currentscience.ac.in

Kumar, Akhilesh; Bachhawat, Anand K. (2012). "Pyroglutamic acid: throwing light on a lightly studied metabolite" (PDF). Current Science 102 (2): 288–297. JSTOR 24083854.

doi.org

dx.doi.org

Schilling, Stephan; Wasternack, Claus; Demuth, Hans-Ulrich (1 de agosto de 2008). "Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution". Biological Chemistry 389 (8): 983–91. PMID 18979624. doi:10.1515/BC.2008.111.
Podell, David N.; Abraham, George N. (marzo de 1978). "A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase". Biochemical and Biophysical Research Communications 81 (1): 176–185. PMID 26343. doi:10.1016/0006-291X(78)91646-7.
Pepeu, Giancarlo; Spignoli, Giacomo (xaneiro de 1989). "Nootropic drugs and brain cholinergic mechanisms". Progress in Neuro-Psychopharmacology and Biological Psychiatry 13: S77–S88. PMID 2694231. doi:10.1016/0278-5846(89)90112-7.
Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A. (11 de novembro de 2011). "Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease". Journal of Biological Chemistry 286 (45): 38825–38832. PMC 3234707. PMID 21965666. doi:10.1074/jbc.R111.288308.
Liss, D. B.; Paden, M. S.; Schwarz, E. S.; Mullins, M. E. (11 de outubro de 2013). "What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?". Clinical Toxicology 51 (9): 817–827. PMID 24111553. doi:10.3109/15563650.2013.844822.
McDougall, Graham J.; Austin-Wells, Vonnette; Zimmerman, Teena (24 de xuño de 2016). "Utility of Nutraceutical Products Marketed for Cognitive and Memory Enhancement". Journal of Holistic Nursing 23 (4): 415–433. PMC 2398696. PMID 16251490. doi:10.1177/0898010105280097.
Šudomová, Miroslava; Hassan, Sherif T. S.; Khan, Haroon; Rasekhian, Mahsa; Nabavi, Seyed Mohammad (21 de agosto de 2019). "A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation". Biomolecules 9 (9): 392. PMC 6770154. PMID 31438631. doi:10.3390/biom9090392.

evidence.nhs.uk

"Hydromol® (Alliance)". British National Formulary. Consultado o 5 de decembro de 2015.

jstor.org

Kumar, Akhilesh; Bachhawat, Anand K. (2012). "Pyroglutamic acid: throwing light on a lightly studied metabolite" (PDF). Current Science 102 (2): 288–297. JSTOR 24083854.

nih.gov

ncbi.nlm.nih.gov

Schilling, Stephan; Wasternack, Claus; Demuth, Hans-Ulrich (1 de agosto de 2008). "Glutaminyl cyclases from animals and plants: a case of functionally convergent protein evolution". Biological Chemistry 389 (8): 983–91. PMID 18979624. doi:10.1515/BC.2008.111.
Podell, David N.; Abraham, George N. (marzo de 1978). "A technique for the removal of pyroglutamic acid from the amino terminus of proteins using calf liver pyroglutamate amino peptidase". Biochemical and Biophysical Research Communications 81 (1): 176–185. PMID 26343. doi:10.1016/0006-291X(78)91646-7.
Pepeu, Giancarlo; Spignoli, Giacomo (xaneiro de 1989). "Nootropic drugs and brain cholinergic mechanisms". Progress in Neuro-Psychopharmacology and Biological Psychiatry 13: S77–S88. PMID 2694231. doi:10.1016/0278-5846(89)90112-7.
Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A. (11 de novembro de 2011). "Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer Disease". Journal of Biological Chemistry 286 (45): 38825–38832. PMC 3234707. PMID 21965666. doi:10.1074/jbc.R111.288308.
Liss, D. B.; Paden, M. S.; Schwarz, E. S.; Mullins, M. E. (11 de outubro de 2013). "What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?". Clinical Toxicology 51 (9): 817–827. PMID 24111553. doi:10.3109/15563650.2013.844822.
DellaVecchia, Matthew J. (decembro de 2013). "Inaccurate Serelaxin Chemical Structure". Pharmacy and Therapeutics 38 (12): 763. PMC 3875272. PMID 24391398.
McDougall, Graham J.; Austin-Wells, Vonnette; Zimmerman, Teena (24 de xuño de 2016). "Utility of Nutraceutical Products Marketed for Cognitive and Memory Enhancement". Journal of Holistic Nursing 23 (4): 415–433. PMC 2398696. PMID 16251490. doi:10.1177/0898010105280097.
Šudomová, Miroslava; Hassan, Sherif T. S.; Khan, Haroon; Rasekhian, Mahsa; Nabavi, Seyed Mohammad (21 de agosto de 2019). "A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation". Biomolecules 9 (9): 392. PMC 6770154. PMID 31438631. doi:10.3390/biom9090392.